Nicholas Kwiatkowski Selected Research

1- (4- (6- (2- (isopropylsulfonyl)phenylamino)- 9H- purin- 2- ylamino)- 3- ethoxyphenyl)piperidin- 4- ol

9/2013

Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas Kwiatkowski Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 02/2011
3	Breast Neoplasms (Breast Cancer) 12/2018 - 02/2011
3	Aneuploidy (Aneuploid) 09/2013 - 03/2008
2	Neuroblastoma 01/2021 - 11/2014
2	Infections 01/2019 - 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Genomic Instability 01/2020
1	Dengue (Dengue Fever) 01/2019
1	Ewing Sarcoma (Sarcoma, Ewing) 12/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Lymphoma (Lymphomas) 01/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 09/2013
1	Chromosomal Instability (Chromosome Stability) 05/2010
1	Carcinogenesis 03/2008
1	Tuberculosis (Tuberculoses) 04/2005

Drug/Important Bio-Agent (IBA)

5	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 11/2014
4	Phosphotransferases (Kinase)IBA 01/2018 - 05/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
3	Pharmaceutical PreparationsIBA 12/2018 - 01/2018
2	YKL-5-124IBA 01/2021 - 01/2020
2	VaccinesIBA 01/2019 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2019
2	Estrogen ReceptorsIBA 12/2018 - 02/2011
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AntibodiesIBA 01/2019
1	ChromatinIBA 12/2018
1	Transcription Factors (Transcription Factor)IBA 12/2018
1	LigandsIBA 12/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Cyclin-Dependent Kinase 9IBA 01/2018
1	Cyclin-Dependent Kinase-Activating KinaseIBA 10/2017
1	Transcription Factor TFIIHIBA 10/2017
1	obatoclaxIBA 01/2017
1	Hormones (Hormone)IBA 09/2015
1	ARQ 197IBA 01/2015
1	Oncogene Proteins (Oncogene Protein)IBA 11/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2013
1	Vincristine (Oncovin)FDA LinkGeneric 09/2013
1	Antimitotic AgentsIBA 09/2013
1	1- (4- (6- (2- (isopropylsulfonyl)phenylamino)- 9H- purin- 2- ylamino)- 3- ethoxyphenyl)piperidin- 4- olIBA 09/2013
1	Aurora Kinase BIBA 05/2010
1	Aurora KinasesIBA 03/2008
1	LanosterolIBA 04/2005
1	IsoenzymesIBA 04/2005

Therapy/Procedure

7	Therapeutics 01/2019 - 11/2014
1	Drug Therapy (Chemotherapy) 01/2017